Immunotherapy against endocrine malignancies: immune checkpoint inhibitors lead the way
We present the challenges and the opportunities of using immune checkpoint inhibitors against these endocrine malignancies, highlighting the breakthroughs and pitfalls that have recently emerged.
Source: Endocrine-Related Cancer - Category: Endocrinology Authors: Cunha, L. L., Marcello, M. A., Rocha-Santos, V., Ward, L. S. Tags: Thematic Review Source Type: research
More News: Adenocarcinoma | Adrenocortical Carcinoma | Brain | Cancer | Cancer & Oncology | Carcinoma | Immunotherapy | Neurology | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer | Study | Thyroid | Thyroid Cancer